All In Biotech

Drug Trial Radar · NCT03373201

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Last checked: Nov 19, 2026Latest source record: Sep 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 320 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

320

Actual

Start

Oct 16, 2017

Primary completion

Mar 5, 2018

Study completion Mar 5, 2018

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Dec 14, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.

Conditions

  • Jet Lag Type Insomnia

Interventions

  • TasimelteonDrug

    Oral capsule

  • PlaceboDrug

    Oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total Sleep Time in the First Two Thirds of the NightTime frame: 1 Day

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Little Rock, Arkansas

  • Vanda Investigational Site

    Alameda, California

  • Vanda Investigational Site

    San Diego, California

  • Vanda Investigational Site

    Santa Monica, California

  • Vanda Investigational Site

    Oakland Park, Florida

  • Vanda Investigational Site

    Atlanta, Georgia

  • Vanda Investigational Site

    Chevy Chase, Maryland

  • Vanda Investigational Site

    St Louis, Missouri

  • Vanda Investigational Site

    New York, New York

  • Vanda Investigational Site

    Cincinnati, Ohio

  • Vanda Investigational Site

    Oklahoma City, Oklahoma

  • Vanda Investigational Site

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.